Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure

Franco Díaz, Camila Cores, Omar Atenas, Nicolás Rodríguez, Raúl Bustos, Pablo Cruces

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection is an infrequent and poorly understood illness. It can present as severe multiorgan failure in children, potentially lethal. Immunomodulation is the empiric treatment because a dysregulated immune response is the primary pathophysiologic mechanism. We present an infant with severe MIS-C, refractory to usual treatment, successfully treated with plasmapheresis.

Original languageEnglish
Pages (from-to)e259-e262
JournalThe Pediatric infectious disease journal
Volume40
Issue number7
DOIs
Publication statusPublished - 1 Jul 2021

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure'. Together they form a unique fingerprint.

Cite this